top of page

INSIGHTS
Search


Health Policies in India and its Implementation
Introduction Following the pandemic India, a developing nation with limited resources, has created a number of policies to expand its...
Aug 8, 20236 min read


Medical Device Registration Process In India: A Primer
In the preceding five years, the medical device industry in India has undergone significant changes, particularly on the regulatory...
Jul 18, 20225 min read


Note on CCI’s Report on the Pharmaceutical Sector
Key findings and observations from a market analysis conducted by the Competition Commission of India (CCI) were revealed on November 18,...
Dec 24, 20216 min read


Enantiomer Patents: Non Obviousness In Secondary Pharmaceutical Patents
Enantiomers, Racemate & Chirality ‘Stereochemistry’ is the study of spatial arrangements of atoms in a molecule. A molecule may be...
Oct 26, 20214 min read


Highlights of National Commission for Indian System of Medicines Bill, (need for preserving, regulating, organizing the Age Old Medicine Systems)
Introduction As a child growing up in India, or even as an adult, each one of us has had a fair experience of how grandmothers in Indian...
Mar 20, 20199 min read
E- Pharmacy In India (Ban Or No Ban)
‘E-pharmacies’ are in quandary after the decisions taken by country’s two High Court’s over the issue of online sale of medicines. The...
Dec 27, 20184 min read
Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim...
Apr 14, 20173 min read
Analysis of the rejection of Lumacaftor (Polymorph) patent application in India
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection...
Jan 11, 20173 min read
Merk’s patent valid but Teva’s Nasonex generic non-infringing
In Merck Sharp & Dohme Corp. (hereinafter referred to be as “Merck”) v. Teva Pharms. United States, Inc. (hereinafter referred to be as...
Dec 27, 20163 min read
Medecins Sans Frontieres (msf) Challenges Pfizer's Patent Application on Pneumonia Vaccine in India
Médecins Sans Frontières (MSF) also known as Doctors Without Borders, an international humanitarian-aid non-governmental organization,...
Mar 18, 20162 min read
Indian Patent Office Rejected Compulsory License Application (C.L.A. No.1 of 2015) for "Saxagliptin" Filed by Lee Pharma Ltd.
In an order dated 19 th January 2016, the Controller of Patents rejected the compulsory license application of Hyderabad based drug...
Feb 9, 20163 min read
Germany’s Boehringer Repudiated Patent on HIV Drug- Nevirapine
The Indian Patent Office has repudiated Germany's Boehringer Ingelheim patent on its key HIV drug- Nevirapine, Patent Application...
Dec 24, 20153 min read
Research Exemption in Indian Patent Law
The research or experimental use exemption permits researchers and product manufacturers to make certain use of a patented invention. The...
Oct 15, 20156 min read
“Well, You have not made out prima facie case for Compulsory License”: Notifies Rajiv Agarwal, Controller General of Patents, Designs and Trademarks, to Lee Pharma!
In a major update for the patent circle (and of course Pharma industry), reportedly, Lee Pharma, a Hyderabad based Indian pharma company,...
Aug 22, 20152 min read


Three Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology and Chemical Patent Portfolios (United States, European and Chinese Scenario)
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Sughrue Mion, PLLC, USA, TEE & HOWE IPATTORNEYS,...
Jul 30, 20151 min read
Division Bench of Delhi High Court passed an interim order in Glenmark v. Symed (July 2015)
The High Court of Delhi has passed an interim order wherein the Justices have made it clear that the appellant (Glenmark) may use any...
Jul 27, 20154 min read
Compulsory Licensing Application against the Patented Drug SAXAGLIPTIN by Lee Pharma
Lee Pharma, a Hyderabad-based Indian pharma company, has filed a Compulsory Licensing (CL) Application (in accordance with Section 84(1)...
Jul 27, 20154 min read
Section 3(D) of Indian Patent Act Strikes Again
India revoked yet another drug patent granted to a German MNC, Boehringer Ingelheim, for its respiratory drug, Spiriva ( crystalline...
Jul 27, 20153 min read
Improving Regulatory Transparency for New Medical Therapies Act
A new act passed in the U.S. house of representative: What will it protect? Patent exclusivity, non-patent exclusivity, or both? Anything...
Apr 9, 20155 min read
Supreme Court stayed the Delhi High Court order of injunction against Glenmark over the Generic drug “Sitagliptin”
Reportedly, Hon’ble Supreme Court of India on Special Leave Petition filed by Glenmark stayed the Delhi High Court order which passed...
Apr 2, 20156 min read
bottom of page


